GENEVA, July 1 -- THALIA filed a patent application (EP2025/086197) for “ANTIBODY-PEPTIDE CONJUGATES FOR IMMUNOTHERAPY OF DISEASES SUCH AS CANCER”. With publication no. WO/2026/125413, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....